Close Menu

Merger Madness

As everyone is busy filling out their March Madness Brackets (and hoping that Duke loses), the Health Blog at the Wall Street Journal has come up with a bracket of their own, seeding pharmas against one another. Some of the results are already in -- Pfizer's taken down Wyeth and Roche's beaten Genentech -- but the winner of the "merger mania" isn't yet clear.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.